Clinical Trial Update: "First-in-human" Study To Assess the Safety and Tolerability of PBF-680 in Male Healthy Volunteers [Phase 1]

View source ↗

Summary

A first-in-human Phase 1 study evaluated the safety and tolerability of the investigational agent PBF-680 in healthy male volunteers. The study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• PBF-680

Snippet

Sponsor: Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau | Conditions: Asthma | Phase 1 | Status: COMPLETED